What is NTRA's current stock price?

As of now, NTRA is trading at $235.54, with a daily change of +0.06%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NTRA Stock Analysis & IQ Rating | Natera

NTRA

Natera

$235.54

+$0.14 | +0.06%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$246.9

MKT CAP

$32.77B

52W Low

$125.38

VOL

$468.12K

P/E Ratio

N/A

AVG VOL

$1.52M

RSI

62.17

TREND

Uptrend

BQ Stock IQ

Login to see Natera (NTRA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NTRA Target Price

Login to display

Strengths

NTRA Rewards

Upgraded on attractively valued

NTRA Rewards

Earnings are forecast to grow

NTRA Price Performance

$237.12 (-0.67%)

$160.97 (+46.33%)

$136.57 (+72.47%)

$175 (+34.59%)

1year

6month

3month

1month

NTRA Risk Level

NTRA has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

NTRA Analysts Opinion

NTRA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

NTRA Analysts Opinion

NTRA Analysts opinion is negative but has improved from the past 3 months

NTRA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

NA

NTRA Street Sentiment

NTRA Street Sentiment is extremely bullish and have negative views on the near-term outlook

NTRA Performance Sentiment

Sentiments overview associated with NTRA events and the stock performance.

79%

21%

Positive

Negative

11 out of 14
events present

3 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$235.40

Resistance
Price

$205.96

Current Price Range

$244.55

Show methods +

NTRA Latest Analysis +

Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Natera (NasdaqGS:NTRA) with a Buy recommendation. Analyst Price Forecast Suggests 3.82% Upside

Tue Dec 23, 2025

$235.40 | -0.07%

Rating

Heres How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today. Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 22.32% on an annualized basis producing an average annual return of 35.12%. Currently Natera has a market capitalization of $31.71 billion.

Tue Dec 16, 2025

$227.40 | -0.47%

Activity

Barclays Maintains Natera (NTRA) Overweight Recommendation. Fintel reports that on December 15 2025 Barclays maintained coverage of Natera (NasdaqGS:NTRA) with a Overweight recommendation. Analyst Price Forecast Suggests 3.87% Upside

Tue Dec 16, 2025

$227.40 | -0.47%

Rating

JP Morgan Maintains Natera (NTRA) Overweight Recommendation. Fintel reports that on December 15 2025 JP Morgan maintained coverage of Natera (NasdaqGS:NTRA) with a Overweight recommendation. Analyst Price Forecast Suggests 2.28% Upside

Tue Dec 16, 2025

$227.40 | -0.47%

Rating

Natera New Test Data Could Change How Doctors Manage Breast Cancer. NTRA) on Wednesday revealed initial translational research results from the international .Data were presented at the San Antonio Breast Cancer Symposium (SABCS).These first data generated from a United States biomarker cohort of 420 patients show that molecular residual disease (MRD) status measured by the Signatera Genome test after surgery (and adjuvant chemotherapy /- radiation if administered) is a highly prognostic biomark

Thu Dec 11, 2025

$231.05 | -0.89%

Activity

Natera Unveils MRD Data From Phase III PALLAS Trial In HR/HER2- Breast Cancer . (RTTNews) - Natera Inc. (NTRA) announced initial translational research results from the international randomized Phase III PALLAS study. The findings were presented at the San Antonio Breast Cancer Symposium (SABCS) and highlight the prognostic value of molecular residual diseas

Thu Dec 11, 2025

$231.05 | -0.89%

Activity

Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation. Fintel reports that on December 8 2025 Canaccord Genuity maintained coverage of Natera (NasdaqGS:NTRA) with a Buy recommendation. Analyst Price Forecast Suggests 2.99% Downside

Tue Dec 9, 2025

$235.53 | -1.51%

Momentum

Rating

Why Is Adaptive Biotechnologies Stock Trading Lower After Nateras Over $400 Million Deal?. ADPT) stock is trading lower on Friday despite no company-specific news likely reacting to NTRA) acquisition of cancer diagnostics firm reimbursement-based milestones.This acquisition reinforces Natera'.s position at the forefront of precision oncology saidWilliam Blair writes that Adaptive Biotechnologies’. stock has been weak in recent sessions as fears over Natera'.s entrance into the blood

Fri Dec 5, 2025

$244.55 | +1.03%

Activity

Momentum

FAQ About NTRA Stock Insights

What is NTRA current stock price?

What are NTRA stock strengths?

What is NTRA Risk Level?

What is NTRA market cap and volume?

What is NTRA current Stock IQ?

Should I buy NTRA stock right now?

Is NTRA a Strong Buy right now?

What does a 'Strong Buy' rating mean for NTRA?

What does a 'Strong Sell' rating mean for NTRA?

What factors influence NTRA's Stock IQ?

Explore our NTRA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NTRA Stock Strategies
Effective Risk Management

FIND US ON

Receive our NTRA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NTRA

Natera

Current Price

$235.54

+$0.14 | +0.06%

52W High

$246.9

MKT CAP

$32.77B

52W Low

$125.38

VOL

$468.12K

P/E Ratio

N/A

AVG VOL

$1.52M

RSI

62.17

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

NTRA Rewards

Upgraded on attractively valued

NTRA Rewards

Earnings are forecast to grow

NTRA Price Performance

$237.12 (-0.67%)

$160.97 (+46.33%)

$136.57 (+72.47%)

$175 (+34.59%)

1year

6month

3month

1month

NTRA Analysts Opinion

NTRA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

NTRA Analysts Opinion

NTRA Analysts opinion is negative but has improved from the past 3 months

NTRA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

NA

NTRA Street Sentiment

NTRA Street Sentiment is extremely bullish and have negative views on the near-term outlook

NTRA Risk Level

NTRA has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

NTRA Performance Sentiment

Sentiments overview associated with NTRA events and the stock performance.

79%

21%

Positive

Negative

11 out of 14
events present

3 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$235.40

Resistance
Price

$205.96

Current Price Range

$244.55

Show methods +

NTRA Stock IQ

Login to unlock Natera (NTRA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NTRA Latest Analysis

Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Natera (NasdaqGS:NTRA) with a Buy recommendation. Analyst Price Forecast Suggests 3.82% Upside

Tue Dec 23, 2025

$235.40 | -0.07%

Rating

Heres How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today. Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 22.32% on an annualized basis producing an average annual return of 35.12%. Currently Natera has a market capitalization of $31.71 billion.

Tue Dec 16, 2025

$227.40 | -0.47%

Activity

Barclays Maintains Natera (NTRA) Overweight Recommendation. Fintel reports that on December 15 2025 Barclays maintained coverage of Natera (NasdaqGS:NTRA) with a Overweight recommendation. Analyst Price Forecast Suggests 3.87% Upside

Tue Dec 16, 2025

$227.40 | -0.47%

Rating

JP Morgan Maintains Natera (NTRA) Overweight Recommendation. Fintel reports that on December 15 2025 JP Morgan maintained coverage of Natera (NasdaqGS:NTRA) with a Overweight recommendation. Analyst Price Forecast Suggests 2.28% Upside

Tue Dec 16, 2025

$227.40 | -0.47%

Rating

Natera New Test Data Could Change How Doctors Manage Breast Cancer. NTRA) on Wednesday revealed initial translational research results from the international .Data were presented at the San Antonio Breast Cancer Symposium (SABCS).These first data generated from a United States biomarker cohort of 420 patients show that molecular residual disease (MRD) status measured by the Signatera Genome test after surgery (and adjuvant chemotherapy /- radiation if administered) is a highly prognostic biomark

Thu Dec 11, 2025

$231.05 | -0.89%

Activity

Natera Unveils MRD Data From Phase III PALLAS Trial In HR/HER2- Breast Cancer . (RTTNews) - Natera Inc. (NTRA) announced initial translational research results from the international randomized Phase III PALLAS study. The findings were presented at the San Antonio Breast Cancer Symposium (SABCS) and highlight the prognostic value of molecular residual diseas

Thu Dec 11, 2025

$231.05 | -0.89%

Activity

Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation. Fintel reports that on December 8 2025 Canaccord Genuity maintained coverage of Natera (NasdaqGS:NTRA) with a Buy recommendation. Analyst Price Forecast Suggests 2.99% Downside

Tue Dec 9, 2025

$235.53 | -1.51%

Momentum

Rating

Why Is Adaptive Biotechnologies Stock Trading Lower After Nateras Over $400 Million Deal?. ADPT) stock is trading lower on Friday despite no company-specific news likely reacting to NTRA) acquisition of cancer diagnostics firm reimbursement-based milestones.This acquisition reinforces Natera'.s position at the forefront of precision oncology saidWilliam Blair writes that Adaptive Biotechnologies’. stock has been weak in recent sessions as fears over Natera'.s entrance into the blood

Fri Dec 5, 2025

$244.55 | +1.03%

Activity

Momentum

Discover NTRA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NTRA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NTRA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NTRA Stock trends

NTRA Stock performance

NTRA Stock analysis

NTRA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NTRA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NTRA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

NTRA Stock Analysis & IQ Rating | Natera

BQ Stock IQ

NTRA Target Price

NTRA Risk Level

NTRA Analysts Opinion

NTRA Street Sentiment

NTRA Performance Sentiment

Technical Price Levels

Explore our NTRA Stock insights

Receive our NTRA Daily Alerts

NTRA Street Sentiment

NTRA Risk Level

Technical Price Levels

Discover NTRA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NTRA. We're here to help you make informed investment decisions today.

Receive our NTRA Daily Alerts

NTRA Alerts